marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-13-2024
Sutro Biopharma Financial Ratios 2011-2024 | STRO
Annual Financial Ratios Sutro Biopharma
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.8 | -2.0 | -3.9 | -22.5 | -1.9 | -1.7 | - | - | - | - | - | - | - |
P/S |
1.3 | 3.5 | 6.6 | 16.9 | 5.2 | 1.6 | - | - | - | - | - | - | - |
EPS |
-1.8 | -2.4 | -2.3 | -1.0 | -2.4 | -6.1 | -44.0 | - | - | - | - | - | - |
EV (Enterprise Value) |
449 M | 381 M | 470 M | 579 M | 277 M | 27.8 M | 128 M | 160 M | - | - | - | - | - |
EBITDA per Share |
-1.37 | -2.43 | -2.03 | -2.05 | -2.21 | -5.68 | - | - | - | - | - | - | - |
EV/EBITDA |
-4.6 | -9.9 | -4.6 | 1.5 | - | - | - | - | - | - | - | ||
PEG |
- | -0.6 | -0.07 | 0.02 | - | - | - | - | - | - | - | ||
P/B |
1.3 | 1.1 | 1.6 | 2.2 | 2.3 | 0.5 | - | - | - | - | - | - | - |
P/CF |
-1.8 | 67.1 | -5.0 | -10.7 | -3.4 | 5.5 | - | - | - | - | - | - | - |
ROE % |
-71.36 | -54.92 | -41.79 | -9.68 | -121.90 | -26.85 | - | - | - | - | - | - | - |
ROA % |
-22.69 | -29.29 | -30.91 | -8.15 | -76.23 | -15.83 | - | - | - | - | - | - | - |
ROCE % |
-59.66 | -59.41 | -39.01 | -21.40 | -56.72 | -19.94 | - | - | - | - | - | - | - |
Current Ratio |
1.5 | 2.1 | 3.8 | 6.4 | 2.7 | 5.8 | - | - | - | - | - | - | - |
DSO |
51.3 | 52.7 | 53.1 | 50.7 | 37.5 | 23.6 | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
51.3 | 52.7 | 53.1 | 50.6 | 37.5 | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
51.3 | 52.7 | 53.1 | 50.6 | 37.5 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Sutro Biopharma
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.59 | -0.59 | -0.95 | - | -0.81 | -0.64 | -0.85 | - | -0.37 | -0.55 | -0.84 | - | -0.67 | -0.13 | -0.66 | -1.48 | 0.46 | 1 | -0.84 | -0.65 | -0.56 | -0.6 | -0.62 | -0.07 | -21.26 | -24.17 | -25.76 | -33.51 | -3.14 | -4.07 | -2.55 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.89 | - | - | - | -0.69 | - | -0.33 | -0.35 | -0.81 | - | -0.67 | -0.16 | -0.39 | - | -0.2 | -0.48 | -0.78 | - | -0.4 | -0.5 | -0.57 | - | -14 | -20.5 | -22.5 | - | 6.05 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-178.64 | -178.61 | -171.96 | -95.73 | -104.21 | -68.86 | -56.40 | -38.67 | -49.57 | -51.98 | -41.54 | -22.78 | -40.71 | -24.65 | -13.65 | -9.68 | -6.87 | -25.23 | -48.33 | -57.00 | -43.02 | -37.59 | -32.26 | -26.85 | -11.64 | -2.55 | 6.22 | 15.38 | 1.30 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-46.46 | -47.08 | -45.55 | -33.68 | -38.55 | -31.99 | -30.45 | -24.49 | -32.81 | -36.26 | -31.23 | -18.50 | -33.60 | -20.94 | -11.65 | -8.15 | -2.50 | -15.11 | -31.51 | -35.65 | -26.86 | -23.19 | -19.54 | -15.83 | -52.79 | -51.69 | -46.51 | -41.11 | -3.48 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-189.94 | -168.02 | -165.87 | -91.77 | -101.01 | -71.09 | -50.52 | -36.26 | -48.49 | -51.48 | -45.40 | -21.60 | -24.80 | -15.77 | -17.52 | -13.92 | -26.94 | -36.77 | -45.82 | -41.61 | -49.33 | -44.03 | -39.22 | -25.81 | -24.83 | -16.13 | -6.94 | 0.98 | 0.98 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.3 | 1.4 | 1.3 | 1.5 | 1.4 | 1.5 | 2.1 | 2.1 | 2.3 | 2.2 | 3.6 | 3.8 | 4.2 | 6.9 | 7.0 | 6.3 | 6.3 | 6.3 | 6.3 | 2.7 | 2.7 | 2.7 | 2.7 | 2.4 | 2.4 | 2.4 | 2.4 | 0.9 | 0.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
72.9 | 67.9 | 236.3 | - | 71.8 | 87.1 | 61.2 | - | 197.6 | 177.6 | 186.8 | - | 115.1 | 26.7 | 39.8 | 61.3 | 28.5 | 53.6 | 75.6 | 50.8 | 46.8 | 54.6 | 46.5 | 11.9 | 29.0 | 39.8 | 32.4 | 36.7 | 4.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
72.9 | 67.9 | 236.3 | - | 71.8 | 87.1 | 61.2 | - | 197.6 | 177.6 | 186.8 | - | 115.1 | 26.7 | 39.8 | 61.3 | 28.5 | 53.6 | 75.6 | 50.8 | 46.8 | 54.6 | 46.5 | 11.9 | 29.0 | 39.8 | 32.4 | 36.7 | 4.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
72.9 | 67.9 | 236.3 | - | 71.8 | 87.1 | 61.2 | - | 197.6 | 177.6 | 186.8 | - | 115.1 | 26.7 | 39.8 | 61.3 | 28.5 | 53.6 | 75.6 | 50.8 | 46.8 | 54.6 | 46.5 | 11.9 | 29.0 | 39.8 | 32.4 | 36.7 | 4.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency